T Scientific Co.,Ltd. (KOSDAQ:057680)

T Scientific Statistics

Total Valuation

T Scientific has a market cap or net worth of KRW 69.47 billion. The enterprise value is 62.01 billion.

Market Cap	69.47B
Enterprise Value	62.01B

Important Dates

The next estimated earnings date is Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

T Scientific has 71.25 million shares outstanding. The number of shares has increased by 4.25% in one year.

Current Share Class	71.25M
Shares Outstanding	71.25M
Shares Change (YoY)	+4.25%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.32%
Owned by Institutions (%)	0.22%
Float	47.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.74
PB Ratio	0.49
P/TBV Ratio	0.51
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-12.64
EV / Sales	1.55
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-9.46

Financial Position

The company has a current ratio of 2.29, with a Debt / Equity ratio of 0.04.

Current Ratio	2.29
Quick Ratio	2.06
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	-0.77
Interest Coverage	-14.47

Financial Efficiency

Return on equity (ROE) is -3.27% and return on invested capital (ROIC) is -3.50%.

Return on Equity (ROE)	-3.27%
Return on Assets (ROA)	-3.07%
Return on Invested Capital (ROIC)	-3.50%
Return on Capital Employed (ROCE)	-5.50%
Revenue Per Employee	570.57M
Profits Per Employee	-70.10M
Employee Count	70
Asset Turnover	0.24
Inventory Turnover	42.05

Taxes

Income Tax	-981.28M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.28% in the last 52 weeks. The beta is -0.32, so T Scientific's price volatility has been lower than the market average.

Beta (5Y)	-0.32
52-Week Price Change	-12.28%
50-Day Moving Average	1,150.00
200-Day Moving Average	1,062.09
Relative Strength Index (RSI)	34.03
Average Volume (20 Days)	481,826

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, T Scientific had revenue of KRW 39.94 billion and -4.91 billion in losses. Loss per share was -68.79.

Revenue	39.94B
Gross Profit	10.66B
Operating Income	-8.24B
Pretax Income	-5.62B
Net Income	-4.91B
EBITDA	-6.94B
EBIT	-8.24B
Loss Per Share	-68.79

Balance Sheet

The company has 12.57 billion in cash and 5.06 billion in debt, giving a net cash position of 7.51 billion or 105.39 per share.

Cash & Cash Equivalents	12.57B
Total Debt	5.06B
Net Cash	7.51B
Net Cash Per Share	105.39
Equity (Book Value)	141.14B
Book Value Per Share	1,980.20
Working Capital	13.18B

Cash Flow

In the last 12 months, operating cash flow was -6.49 billion and capital expenditures -64.77 million, giving a free cash flow of -6.56 billion.

Operating Cash Flow	-6.49B
Capital Expenditures	-64.77M
Free Cash Flow	-6.56B
FCF Per Share	-92.01

Margins

Gross margin is 26.69%, with operating and profit margins of -20.63% and -12.29%.

Gross Margin	26.69%
Operating Margin	-20.63%
Pretax Margin	-14.08%
Profit Margin	-12.29%
EBITDA Margin	-17.36%
EBIT Margin	-20.63%
FCF Margin	n/a

Dividends & Yields

T Scientific does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.25%
Shareholder Yield	-4.25%
Earnings Yield	-7.06%
FCF Yield	-9.44%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

T Scientific has an Altman Z-Score of 1.8 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.8
Piotroski F-Score	3